Velocity is the world's leading integrated site organization.
Sponsors and CROs trust Velocity to deliver high-quality clinical trial data and patient care with unprecedented efficiency.
Simplify everything from site selection to study close-out
Velocity unifies operational processes to provide world-class sites, reliable enrollment, and predictably high performance for your trials.
News
Respiratory Health Priorities are Changing Across Europe – What Role Do Clinical Trial Sites Have to Play?
For decades, research into respiratory health has centered on conditions such as asthma and chronic obstructive pulmonary disease (COPD), predominantly because of their high prevalence. However, the incidence of respiratory … Read more
Henrick Watz, MD, PhD, Leads Ahrensburg, Germany Site as Top Enroller in Global COPD Trial
Another outstanding achievement for Henrik Watz, MD, PhD, and our team in Ahrensburg, Germany! They led enrollment for a global chronic obstructive pulmonary disease (COPD) trial, more than doubling the … Read more
Kris Kowdley, MD, Presents Positive Late-Breaking Data for Ipsen’s Iqirvo® at AASLD
Kris Kowdley, MD, AGAF, FAASLD, FACP, FACG, presented late-breaking data for Iqirvo® (elafibranor), Ipsen’s treatment for primary biliary cholangitis (PBC), at American Association for the Study of Liver Diseases (AASLD). … Read more
The Start of Germany’s National Pharma Strategy: Implications for CROs and Clinical Trials
Over the past decade, Germany’s share of global clinical trial activities has dropped year on year. The country accounted for just 3.9% of trials in 2021, down from 7.2% in … Read more